J&J Q1 Financials Are All About COVID-19 Progress And Impact

 
• By Jessica Merrill

Johnson & Johnson will move a vaccine candidate for COVID-19 into clinical testing in September and lowered 2020 financial guidance as a result of the pandemic. Pharma sales were resilient, however.

SC2004_JNJ Sign_1524542537_1200.jpg
J&J revised 2020 forecasts as a result of COVID-19 • Source: Shutterstock

More from Earnings

More from Business